{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T09:54:43Z","timestamp":1756893283785},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,17]]},"DOI":"10.7759\/cureus.22325","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T13:35:41Z","timestamp":1645104941000},"source":"Crossref","is-referenced-by-count":3,"title":["Can the Reduction of Cytokines Stop the Progression of Sepsis?"],"prefix":"10.7759","author":[{"given":"Suna","family":"Koc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Celebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferhat","family":"Hanikoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalcin","family":"Polat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul","family":"Borku  Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Dokur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turkan","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Yavuzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Sami","family":"Islamoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahir","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokay","family":"Vardar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lke","family":"Kupeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus DC","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013, 369:840-51. 10.1056\/NEJMra1208623","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5301\/ijao.5000591","article-title":"Continuous hemoadsorption with a cytokine adsorber during sepsis - a review of the literature","volume":"40","author":"Houschyar KS","year":"2017","unstructured":"Houschyar KS, Pyles MN, Rein S, et al.. Continuous hemoadsorption with a cytokine adsorber during sepsis - a review of the literature. Int J Artif Organs. 2017, 40:205-11. 10.5301\/ijao.5000591","journal-title":"Int J Artif Organs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14989","article-title":"Compliance with the surviving sepsis campaign bundle: a multicenter study from Turkey","volume":"13","author":"Bahar \u0130","year":"2021","unstructured":"Bahar \u0130, Oksuz H, \u015eeno\u011flu N, et al.. Compliance with the surviving sepsis campaign bundle: a multicenter study from Turkey. Cureus. 2021, 13:e14989. 10.7759\/cureus.14989","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/510436","article-title":"Sepsis: from pathophysiology to individualized patient care","volume":"2015","author":"L\u00e1szl\u00f3 I","year":"2015","unstructured":"L\u00e1szl\u00f3 I, Tr\u00e1sy D, Moln\u00e1r Z, Fazakas J. Sepsis: from pathophysiology to individualized patient care. J Immunol Res. 2015, 2015:510436. 10.1155\/2015\/510436","journal-title":"J Immunol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss RS","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016, 2:16045. 10.1038\/nrdp.2016.45","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016","volume":"43","author":"Rhodes A","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, et al.. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017, 43:304-77. 10.1007\/s00134-017-4683-6","journal-title":"Intensive Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016","volume":"45","author":"Rhodes A","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, et al.. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017, 45:486-552. 10.1097\/CCM.0000000000002255","journal-title":"Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the `Cytokine Storm' in COVID-19","volume":"80","author":"Ye Q","year":"2020","unstructured":"Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect. 2020, 80:607-13. 10.1016\/j.jinf.2020.03.037","journal-title":"J Infect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial","volume":"301","author":"Cruz DN","year":"2009","unstructured":"Cruz DN, Antonelli M, Fumagalli R, et al.. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009, 301:2445-52. 10.1001\/jama.2009.856","journal-title":"JAMA"},{"key":"ref11","article-title":"Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock","volume":"35","author":"Kreymann KG","year":"2007","unstructured":"Kreymann KG, de Heer G, Nierhaus A, Kluge S. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med. 2007, 35:2677-85.","journal-title":"Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000060105","article-title":"Extracorporeal blood purification therapy for sepsis and systemic inflammation: its biological rationale","volume":"2001","author":"Bellomo R","year":"2001","unstructured":"Bellomo R, Baldwin I, Ronco C. Extracorporeal blood purification therapy for sepsis and systemic inflammation: its biological rationale. Contrib Nephrol. 2001, 2001:367-74. 10.1159\/000060105","journal-title":"Contrib Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000492379","article-title":"Clinical utility of extracorporeal cytokine hemoadsorption therapy: a literature review","volume":"46","author":"Bonavia A","year":"2018","unstructured":"Bonavia A, Groff A, Karamchandani K, Singbartl K. Clinical utility of extracorporeal cytokine hemoadsorption therapy: a literature review. Blood Purif. 2018, 46:337-49. 10.1159\/000492379","journal-title":"Blood Purif"},{"key":"ref14","unstructured":"Reshma Tewari. role of Cytosorb\u00ae in optimization of vasopressors and reduction of sepsis scores: a case series. (2015). Accessed: February 12, 2022: https:\/\/cytosorb-therapy.com\/wpcontent\/uploads\/2015\/10\/Tewari_Poster_2015_10_02_CytoSorb.pdf."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5492\/wjccm.v10.i1.22","article-title":"Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb\u00ae) in patients with sepsis and septic shock","volume":"10","author":"Paul R","year":"2021","unstructured":"Paul R, Sathe P, Kumar S, Prasad S, Aleem M, Sakhalvalkar P. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb\u00ae) in patients with sepsis and septic shock. World J Crit Care Med. 2021, 10:22-34. 10.5492\/wjccm.v10.i1.22","journal-title":"World J Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2018.11.003","article-title":"Extracorporeal cytokine adsorption in septic shock: a proof of concept randomized, controlled pilot study","volume":"49","author":"Hawchar F","year":"2019","unstructured":"Hawchar F, L\u00e1szl\u00f3 I, \u00d6veges N, Tr\u00e1sy D, Ondrik Z, Molnar Z. Extracorporeal cytokine adsorption in septic shock: a proof of concept randomized, controlled pilot study. J Crit Care. 2019, 49:172-8. 10.1016\/j.jcrc.2018.11.003","journal-title":"J Crit Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5301\/ijao.5000583","article-title":"Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series","volume":"40","author":"Tr\u00e4ger K","year":"2017","unstructured":"Tr\u00e4ger K, Skrabal C, Fischer G, et al.. Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass - a case series. Int J Artif Organs. 2017, 40:240-9. 10.5301\/ijao.5000583","journal-title":"Int J Artif Organs"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033095","article-title":"Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma","volume":"7","author":"Gouel-Ch\u00e9ron A","year":"2012","unstructured":"Gouel-Ch\u00e9ron A, Allaouchiche B, Guignant C, Davin F, Floccard B, Monneret G. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One. 2012, 7:e33095. 10.1371\/journal.pone.0033095","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2010.02705.x","article-title":"Multiplex cytokine profiling in patients with sepsis","volume":"119","author":"Mera S","year":"2011","unstructured":"Mera S, Tatulescu D, Cismaru C, et al.. Multiplex cytokine profiling in patients with sepsis. APMIS. 2011, 119:155-63. 10.1111\/j.1600-0463.2010.02705.x","journal-title":"APMIS"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001472","article-title":"Reversal of acute kidney injury-induced neutrophil dysfunction: a critical role for resistin","volume":"44","author":"Singbartl K","year":"2016","unstructured":"Singbartl K, Miller L, Ruiz-Velasco V, Kellum JA. Reversal of acute kidney injury-induced neutrophil dysfunction: a critical role for resistin. Crit Care Med. 2016, 44:e492-501. 10.1097\/CCM.0000000000001472","journal-title":"Crit Care Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/ijccm.IJCCM_422_17","article-title":"Mortality prediction using Acute Physiology and Chronic Health Evaluation II and Acute Physiology and Chronic Health Evaluation IV scoring systems: is there a difference?","volume":"22","author":"Venkataraman R","year":"2018","unstructured":"Venkataraman R, Gopichandran V, Ranganathan L, Rajagopal S, Abraham BK, Ramakrishnan N. Mortality prediction using Acute Physiology and Chronic Health Evaluation II and Acute Physiology and Chronic Health Evaluation IV scoring systems: is there a difference?. Indian J Crit Care Med. 2018, 22:332-5. 10.4103\/ijccm.IJCCM_422_17","journal-title":"Indian J Crit Care Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1662-9","article-title":"Hemoadsorption by CytoSorb in septic patients: a case series","volume":"21","author":"Kogelmann K","year":"2017","unstructured":"Kogelmann K, Jarczak D, Scheller M, Dr\u00fcner M. Hemoadsorption by CytoSorb in septic patients: a case series. Crit Care. 2017, 21:74. 10.1186\/s13054-017-1662-9","journal-title":"Crit Care"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2588-1","article-title":"Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study","volume":"23","author":"Brouwer WP","year":"2019","unstructured":"Brouwer WP, Duran S, Kuijper M, Ince C. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Crit Care. 2019, 23:317. 10.1186\/s13054-019-2588-1","journal-title":"Crit Care"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-321398","article-title":"Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia","volume":"117","author":"Barsam SJ","year":"2011","unstructured":"Barsam SJ, Psaila B, Forestier M, et al.. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood. 2011, 117:5723-32. 10.1182\/blood-2010-11-321398","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/84217-can-the-reduction-of-cytokines-stop-the-progression-of-sepsis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:41Z","timestamp":1707507941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/84217-can-the-reduction-of-cytokines-stop-the-progression-of-sepsis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.22325","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,17]]}}}